日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Neoadjuvant palbociclib and endocrine therapy versus chemotherapy in ER + /HER2- breast cancer: a randomized phase II trial

新辅助帕博西尼联合内分泌治疗与化疗治疗ER+/HER2-乳腺癌:一项随机II期试验

Matikas, Alexios; Tzoras, Evangelos; Sarafidis, Michail; Sifakis, Emmanouil G; Bjöhle, Judith; Barnekow, Elin; Margolin, Sara; Isaksson-Friman, Erika; Kessler, Luisa Edman; Zouzos, Athanasios; Johansson, Hemming; Hellström, Mats; Agartz, Susanne; Grybäck, Per; Salgkamis, Dimitrios; Zerdes, Ioannis; Wang, Kang; Hartman, Johan; Acs, Balazs; Sun, Wenwen; Boyaci, Ceren; Villacampa, Guillermo; Pascual, Tomas; Gavila, Joaquin; Prat, Aleix; Perou, Charles; Brandberg, Yvonne; Bergh, Jonas; Hatschek, Thomas; Foukakis, Theodoros

Salivary Proteomic Signatures Reveal Novel Mechanistic Insights into Moderate Dental Fluorosis Pathogenesis and Oral Homeostasis Disruption

唾液蛋白质组学特征揭示中度牙齿氟斑症发病机制和口腔稳态破坏的新机制

Pumchan, Ansaya; Gavila, Patcharaporn; Khieota, Thutchima; Jung, Han-Sung; Sriwattanapong, Kanokwan; Porntaveetus, Thantrira

Extended follow-up of palbociclib with fulvestrant or letrozole for endocrine-sensitive, hormone receptor-positive/HER2-negative advanced breast cancer in the PARSIFAL trial

在PARSIFAL试验中,对帕博西尼联合氟维司群或来曲唑治疗内分泌敏感、激素受体阳性/HER2阴性晚期乳腺癌患者进行了延长随访。

Llombart-Cussac, A; Pérez-García, J M; Bellet, M; Dalenc, F; Gil-Gil, M; Ruiz-Borrego, M; Gavila, J; Schmid, P; Zamora, P; Wheatley, D; Martínez-de Dueñas, E; Amillano, K; Di Cosimo, S; Anton, A; Cottu, P; Shimizu, E; Fernandez, M; Sampayo-Cordero, M; Cortés, J

The metagenome and metabolome signatures of dental biofilms associated with severe dental fluorosis

与严重牙齿氟斑症相关的牙菌斑的宏基因组和代谢组特征

Ajrithirong, Penpitcha; Krasaesin, Annop; Sriarj, Wannakorn; Gavila, Patcharaporn; Chetruengchai, Wanna; Sriwattanapong, Kanokwan; Manaspon, Chawan; Samaranayake, Lakshman; Porntaveetus, Thantrira

Salivary proteomic signatures in severe dental fluorosis

严重氟斑牙的唾液蛋白质组学特征

Patcharaporn Gavila, Penpitcha Ajrithirong, Supoj Chumnanprai, Nuttiya Kalpongnukul, Trairak Pisitkun, Soranun Chantarangsu, Kanokwan Sriwattanapong, Junji Tagami, Thantrira Porntaveetus

Independent Validation of the PAM50-Based Chemo-Endocrine Score (CES) in Hormone Receptor-Positive HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2-Based Therapy

独立验证基于PAM50的化疗内分泌评分(CES)在接受新辅助抗HER2治疗的激素受体阳性HER2阳性乳腺癌中的应用

Pascual, Tomás; Fernandez-Martinez, Aranzazu; Tanioka, Maki; Dieci, M Vittoria; Pernas, Sonia; Gavila, Joaquin; Guarneri, Valentina; Cortes, Javier; Villagrasa, Patricia; Chic, Núria; Vidal, Maria; Adamo, Barbara; Muñoz, Montserrat; Griguolo, Gaia; Llombart, Antonio; Conte, Pierfranco; Oliveira, Mafalda; Conte, Benedetta; Paré, Laia; Galvan, Patricia; Carey, Lisa A; Perou, Charles M; Prat, Aleix

A polymorphism at the 3'-UTR region of the aromatase gene defines a subgroup of postmenopausal breast cancer patients with poor response to neoadjuvant letrozole.

芳香化酶基因 3'-UTR 区域的多态性定义了对新辅助来曲唑反应较差的绝经后乳腺癌患者的一个亚组

Garcia-Casado Zaida, Guerrero-Zotano Angel, Llombart-Cussac Antonio, Calatrava Ana, Fernandez-Serra Antonio, Ruiz-Simon Amparo, Gavila Joaquin, Climent Miguel A, Almenar Sergio, Cervera-Deval Jose, Campos Josefina, Albaladejo Carlos Vazquez, Llombart-Bosch Antonio, Guillem Vicente, Lopez-Guerrero Jose A